bell
The current prices are delayed by 15 mins, login to check live prices.
Fredun Pharmaceuticals Ltd share price logo

Fredun Pharmaceuticals Ltd

(539730)

₹6723.09%

as on 04:01PM, 21 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Fredun Pharmaceuticals Ltd Performance

  • Day's Low

    Day's High

    ₹658.2
    ₹703.9
  • 52 Week's Low

    52 Week's High

    ₹650
    ₹1,054
1 Month Return-5.06 %
3 Month Return-11.63 %
1 Year Return-19.39 %
Previous Close₹693.45
Open₹703.90
Volume8,304.00
Upper Circuit-
Lower Circuit-
Market Cap₹325.86Cr

Fredun Pharmaceuticals Ltd Key Statistics

P/E Ratio0
PEG Ratio0
Market Cap₹325.86 Cr
P/B Ratio2.81
EPS0
Dividend Yield0
SectorPharmaceuticals
ROE14.34

Fredun Pharmaceuticals Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
NA₹325.86 Cr42.66%0.74NANA
NA₹64.17 Cr258.28%0.50NANA
NA₹123.98 Cr53.7%0.69NANA
NA₹94.27 Cr188.71%0.51NANA
NA₹1,388.42 Cr84.92%0.51₹25 Cr₹212 Cr

About Fredun Pharmaceuticals Ltd

Established in 1987 as a private limited company, Fredun Pharmaceuticals (FPL) was eventually transformed into a public limited company in 1994. Initially, the promoters had set up D N Pharma to manufacture and export pharmaceutical pharmaceutical formulations to Afghanistan, West Africa and other nearby countries. However, starting from 1993, the company shifted to FPL which focused on developing tablet, capsules, dry syrups and ointments. It commenced commercial production in August 1994 with loan and license from Cipla and Merind.

Consequently, FPL was approved to be listed on the stock exchange in April 1996, and decided to use the funding for international expansion, repaying term loans, and reducing interest burden. Furthermore, FPL is continually registering its products across various countries with the hopes of increasing its overall turnover and boosting export orders. Currently, FPL is successfully registering drugs in countries such as Nepal, Tanzania, Uganda, and Sri Lanka.

Share Price: ₹672.00 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹325.86Cr as of today
Chairperson Name: Daulat N Medhora
OrganisationFredun Pharmaceuticals Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Insights on Fredun Pharmaceuticals Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 49.24% to 49.48% in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 81.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 78.0%

  • imgNEGATIVE IMPACT

    Promoter Holding Down

    img

    Promoters have decreased holdings from 49.17% to 48.93% in Sep 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 6 months, Fredun Pharma stock has moved down by -17.7%

Fredun Pharmaceuticals Ltd Financials

Value in ₹ crore
Details2021202220232024
Total Assets₹161.61Cr (-)₹187.00Cr (↑15.71%)₹257.27Cr (↑37.58%)₹307.59Cr (↑19.56%)
Total Liabilities₹118.54Cr (-)₹118.94Cr (↑0.34%)₹160.89Cr (↑35.27%)₹186.12Cr (↑15.68%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹10.64Cr (-)₹0.17Cr (↓101.60%)-₹2.38Cr (↓1,500.00%)-₹14.41Cr (↑505.46%)-₹0.44Cr (↓96.95%)
0

Fredun Pharmaceuticals Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
48.93%
-0.48
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
49.48%
0.49
Others
1.59%
-0.48

Fredun Pharmaceuticals Ltd Key Indicators

Details20202021202220232024
Return On Equity %4.734.7611.4113.1514.34

Fredun Pharmaceuticals Ltd Earnings and Dividends

  • Fredun Pharmaceuticals Ltd Earnings Results

    Fredun Pharmaceuticals Ltd’s net profit jumped 8.38% since last year same period to ₹4.27Cr in the Q2 2024-2025. On a quarterly growth basis, Fredun Pharmaceuticals Ltd has generated 3.39% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Fredun Pharmaceuticals Ltd Dividends May,2024

    In the quarter ending March 2024, Fredun Pharmaceuticals Ltd has declared dividend of ₹0.70 - translating a dividend yield of 0.20%.

    Read More about Dividends

Fredun Pharmaceuticals Ltd Technicals Summary

Bearish

Neutral

Bullish

Bearish

Fredun Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.

FAQs on Fredun Pharmaceuticals Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Fredun Pharmaceuticals Ltd shares.

Fredun Pharmaceuticals Ltd (539730) share price today is ₹672

Fredun Pharmaceuticals Ltd is not listed on NSE

Fredun Pharmaceuticals Ltd is listed on BSE

  • Today’s highest price of Fredun Pharmaceuticals Ltd is ₹703.9.
  • Today’s lowest price of Fredun Pharmaceuticals Ltd is ₹658.2.

Today’s traded volume of Fredun Pharmaceuticals Ltd(539730) is 8,304.00.

Today’s market capitalisation of Fredun Pharmaceuticals Ltd(539730) is ₹325.86Cr.

Fredun Pharmaceuticals Ltd(539730Price
52 Week High
₹1054
52 Week Low
₹650

Fredun Pharmaceuticals Ltd(539730) share price is ₹672. It is down -36.24% from its 52 Week High price of ₹1054

Fredun Pharmaceuticals Ltd(539730) share price is ₹672. It is up 3.38% from its 52 Week Low price of ₹650

Fredun Pharmaceuticals Ltd(539730Returns
1 Day Returns
-21.45%
1 Month Returns
-5.06%
3 Month Returns
-11.63%
1 Year Returns
-19.39%